Clinical Trials Directory

Trials / Completed

CompletedNCT07075796

Study of the Performance of the GLUCUBE System in Patients With Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
iGluco · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective, single center, open label clinical investigation. The primary objective of the study is to evaluate the performance of GLUCUBE in patients with diabetes type 2 and how the accuracy of the system improves as the time of use by the patient increases.

Detailed description

Current methods of measuring blood glucose, glucometers, although minimally invasive, can be painful as they require puncturing the fingertip with a prick device and drawing a drop of blood, which is applied to a disposable test strip. This minimal invasiveness can cause discomfort and discourage the user from testing their blood glucose levels as frequently as necessary, leading to poor glycemic control. Due to the non-invasive nature of the GLUCUBE system, it provides glucose level information safely and painlessly, avoiding any discomfort to the user. It is low cost as it uses commonly used electronic components and does not require test strips or other consumables that would increase the ongoing cost of the device. The performance of the GLUCUBE system has already been evaluated in comparison to the standard glucometer (Ascensia Contour®Next) in adult patients with and without diabetes. The primary objective of this clinical investigation is to evaluate the performance of GLUCUBE in patients with diabetes type 2 and how the accuracy of the system improves as the time of use by the patient increases.

Conditions

Interventions

TypeNameDescription
DEVICEGLUCUBE systemA non-invasive system to monitor and measure the blood glucose compared to the standard glucometer in a group subjects

Timeline

Start date
2025-06-02
Primary completion
2025-11-28
Completion
2025-11-28
First posted
2025-07-20
Last updated
2026-01-13

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07075796. Inclusion in this directory is not an endorsement.